P. Khaw

发表

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

H. Putter, C. Haie-meder, H. Kitchener, 2018, The Lancet. Oncology.

Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial.

H. Putter, C. Haie-meder, H. Kitchener, 2016, The Lancet. Oncology.

Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial

M. Stockler, L. Mileshkin, A. Capp, 2016, British Journal of Cancer.

Patterns of practice survey for brachytherapy for cervix cancer in Australia and New Zealand

S. Vinod, L. Mileshkin, S. van Dyk, 2017, Journal of medical imaging and radiation oncology.

F‐18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma

V Kalff, J. Matthews, D. Ball, 2001, Cancer.

Carcinoma of the cervix in elderly patients treated with radiotherapy: patterns of care and treatment outcomes

K. Narayan, M. Lin, S. Kondalsamy-Chennakesavan, 2016, Journal of gynecologic oncology.

Smokers With Cervix Cancer Have More Uterine Corpus Invasive Disease and an Increased Risk of Recurrence After Treatment With Chemoradiation

L. Mileshkin, K. Narayan, S. Kondalsamy-Chennakesavan, 2014, International Journal of Gynecologic Cancer.

Why quality assurance is necessary in gynecologic radiation oncology

S. van Dyk, A. Moore, D. Chang, 2022, International Journal of Gynecological Cancer.

Carcinoid tumour of the orbital muscles: A rare occurrence.

G. Duchesne, P. Khaw, D. Ball, 2001, Australasian radiology.

p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial

P. Pollock, C. Genestie, H. Kitchener, 2022, Modern Pathology.

Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The randomized phase III OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274).

B. Monk, M. Stockler, V. Gebski, 2021 .

Long-term toxicity and health-related quality of life after adjuvant chemoradiotherapy or radiotherapy alone for high-risk endometrial cancer in the randomised PORTEC-3 trial.

H. Putter, C. Haie-meder, H. Kitchener, 2020, International journal of radiation oncology, biology, physics.

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

C. Genestie, H. Mackay, A. Fyles, 2022, British Journal of Cancer.

Prognostic Significance of Lymphovascular Space Invasion and Nodal Involvement in Intermediate- and High-Risk Endometrial Cancer Patients Treated With Curative Intent Using Surgery and Adjuvant Radiotherapy

L. Mileshkin, K. Narayan, S. Kondalsamy-Chennakesavan, 2011, International Journal of Gynecologic Cancer.

Clinical outcomes from an innovative protocol using serial ultrasound imaging and a single MR image to guide brachytherapy for locally advanced cervix cancer.

S. van Dyk, K. Narayan, Michal Schneider, 2016, Brachytherapy.

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

H. Putter, C. Haie-meder, H. Kitchener, 2019, The Lancet. Oncology.

Stage IB cervix cancer with nodal involvement treated with primary surgery or primary radiotherapy: Patterns of failure and outcomes in a contemporary population

K. Narayan, S. Kondalsamy-Chennakesavan, D. Bernshaw, 2016, Journal of medical imaging and radiation oncology.

Results of the Australasian (Trans‐Tasman Oncology Group) radiotherapy benchmarking exercise in preparation for participation in the PORTEC‐3 trial

P. Metcalfe, L. Mileshkin, M. Bailey, 2016, Journal of medical imaging and radiation oncology.

Tailoring Adjuvant Radiotherapy in Endometrial Cancer

K. Narayan, M. Lin, D. Bernshaw, 2017, Indian Journal of Gynecologic Oncology.

Ultrasound guided conformal brachytherapy of cervix cancer: survival, patterns of failure, and late complications

L. Mileshkin, S. van Dyk, K. Narayan, 2014, Journal of gynecologic oncology.

Final results of the international randomized PORTEC-3 trial of adjuvant chemotherapy and radiation therapy (RT) versus RT alone for women with high-risk endometrial cancer.

H. Putter, C. Haie-meder, H. Kitchener, 2017 .

Ultrasound-guided Brachytherapy for Cervix Cancer.

D. Chang, D. Bernshaw, P. Khaw, 2021, Clinical oncology (Royal College of Radiologists (Great Britain)).

Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.

B. Monk, M. Stockler, V. Gebski, 2023, The Lancet. Oncology.

ENhAncing Lifestyle Behaviors in EndometriaL CancEr (ENABLE): A Pilot Randomized Controlled Trial

L. Denehy, L. Mileshkin, K. Gough, 2022, Integrative cancer therapies.

OC-0369: Long-Term Quality of Life after (chemo)radiotherapy for high-risk Endometrial Cancer in PORTEC-3

H. Putter, D. Katsaros, J. Ledermann, 2020 .

Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial

A. Fyles, M. Bailey, V. Do, 2021, Clinical Oncology.

Radiotherapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of Three-Dimensional Conformal Radiotherapy versus Intensity-Modulated Radiotherapy.

H. Putter, C. Haie-meder, H. Kitchener, 2021, International journal of radiation oncology, biology, physics.

In response to Kirisits, Schmid, Beriwal, and Potter.

S. van Dyk, K. Narayan, M. Lin, 2016, Brachytherapy.

Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand.

P. Allan, P. Khaw, Hugo Saunders, 2024, The Australian & New Zealand journal of obstetrics & gynaecology.

17 Pet scanning in 100 radical radiation therapy candidates with non-small cell lung cancer: High impact on staging and management and delineation of a subgroup with poor survival

M. Millward, D. Ball, R. Hicks, 1999 .